Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Frontiers in Pediatrics|October 21, 2021
Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German ChildrenOtto Laub, Georg Leipold, Antoaneta A Toncheva, et al.Viruses|July 2, 2021
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020Ralf Wagner, David Peterhoff, Stephanie Beileke, et al.Clinical Epigenetics|June 13, 2026
DNAm landscape up to 4 months post SARS-CoV-2 infection: insights from four population-based cohortsPamela R Matías-García, Liye Lai, Thomas Delerue, et al.Journal of Extracellular Biology|October 31, 2025
Two Sides of the Same Coin-Mechanistic Insight, Diagnostic Application and Therapeutic Translation of Bacterial and Host-Derived Extracellular VesiclesPhilipp Arnold, Fanni Annamária Boros, Jochen Mattner, et al.Immunity, Inflammation and Disease|December 6, 2017
Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cellsLoveline N Ngu, Nadesh N Nji, Georgia Ambada, et al.Nature Communications|April 26, 2020
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritisNarges Tajik, Michael Frech, Oscar Schulz, et al.Nature Communications|July 26, 2020
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversionDavid Simon, Koray Tascilar, Gerhard Krönke, et al.Ebiomedicine|October 7, 2022
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2Emanuel Vogel, Katharina Kocher, Alina Priller, et al.European Journal of Immunology|August 6, 2021
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection modelAntonia Sophia Peter, Edith Roth, Sebastian R Schulz, et al.Nature Medicine|January 28, 2022
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concernPaul R Wratil, Marcel Stern, Alina Priller, et al.Pageof 10